文献速递重症综合管理与镇静镇痛心脑血管急症

UNLOADERS-PVAD撤机评分:预测微轴流泵支持的肺源性休克患者撤机后不良事件

UNLOADERS-PVAD Weaning Score: predicting post-weaning adverse events in cardiogenic shock patients supported by microaxial flow pump.
PubMed 文献 · J Intensive Care · 2025-11-04
一句话结论UNLOADERS-PVAD评分由4项临床和3项血流动力学因素构成,可线性分层微轴流泵撤机后30天全因死亡或再植入机械循环支持风险(AUC 0.786)。

本研究为UNLOADERS-PVAD观察性登记研究的二次分析,纳入日本3家机构连续接受经皮心室辅助装置(PVAD)支持的肺源性休克患者304例,在撤机前即刻评估13项临床和9项血流动力学因素,采用LASSO法筛选与30天事件(全因死亡或撤机后再引入机械循环支持)相关的因素。最终纳入4项临床因素(女性、肾脏替代治疗、使用多种血管升压药和/或正性肌力药、乳酸升高)和3项血流动力学因素(心率升高、肺动脉楔压升高、心脏做功降低)构建UNLOADERS-PVAD撤机评分。该评分可线性分层30天事件风险,预测准确性良好(AUC 0.786;95%CI 0.712-0.860)。

要点

  • 在304例微轴流泵支持的肺源性休克患者中,撤机前即刻的4项临床因素和3项血流动力学因素与30天全因死亡或再引入机械循环支持独立相关。
  • UNLOADERS-PVAD撤机评分可线性分层30天事件风险,预测准确性AUC为0.786(95%CI 0.712-0.860)。
  • 评分纳入的临床因素为女性、肾脏替代治疗、使用多种血管升压药和/或正性肌力药、乳酸升高。
  • 评分纳入的血流动力学因素为心率升高、肺动脉楔压升高、心脏做功降低。
  • 该评分有助于在PVAD撤机前进行风险分层,指导关于进一步干预的临床决策。

适用人群与场景

  • 日本3家机构连续纳入的接受经皮心室辅助装置(PVAD)支持的肺源性休克患者,共304例。
  • 二次分析人群为UNLOADERS-PVAD观察性登记研究中接受PVAD支持并评估撤机的患者。

诊断标准与关键阈值

  • 30天事件定义为PVAD撤机后全因死亡或再引入机械循环支持。
  • UNLOADERS-PVAD撤机评分基于撤机前即刻评估的4项临床因素(女性、肾脏替代治疗、使用多种血管升压药和/或正性肌力药、乳酸升高)和3项血流动力学因素(心率升高、肺动脉楔压升高、心脏做功降低)构建,用于分层30天事件风险。

研究设计与关键结果

  • 本研究为UNLOADERS-PVAD观察性登记研究的二次分析,纳入日本3家机构连续接受PVAD支持的肺源性休克患者304例。
  • 采用LASSO法从撤机前即刻评估的13项临床和9项血流动力学因素中筛选与30天事件(全因死亡或撤机后再引入机械循环支持)相关的因素。
  • 最终选择4项临床因素(女性、肾脏替代治疗、使用多种血管升压药和/或正性肌力药、乳酸升高)和3项血流动力学因素(心率升高、肺动脉楔压升高、心脏做功降低)构建UNLOADERS-PVAD撤机评分。
  • 该评分可线性分层30天事件风险,预测准确性AUC为0.786(95%CI 0.712-0.860)。

证据类型、等级与局限

  • 证据类型:观察性登记研究的二次分析。
  • 预测模型AUC为0.786(95%CI 0.712-0.860)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该评分系统有助于在PVAD撤机前进行准确的风险分层,指导关于进一步干预的临床决策。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Limited data are available on risk stratification in patients undergoing weaning from percutaneous ventricular assist devices (PVADs). We aimed to identify factors associated with adverse events following PVAD weaning and to construct a predictive scoring system.

METHODS: This study was a secondary analysis of the UNLOADERS-PVAD study, an observational registry involving three participating institutions in Japan. Consecutive patients with cardiogenic shock who received PVAD support were analyzed for 13 clinical and nine hemodynamic factors assessed immediately prior to PVAD explantation, using the least absolute shrinkage and selection operator (LASSO) method. Risk factors associated with 30-day events, defined as all-cause mortality or reintroduction of mechanical circulatory support after PVAD weaning, were identified.

RESULTS: Among 304 patients, four clinical factors (female sex, renal replacement therapy, use of multiple vasopressors and/or inotropes, and elevated lactate levels) and three hemodynamic factors (elevated heart rate, elevated pulmonary artery wedge pressure, and lower cardiac power output) immediately prior to PVAD explantation were selected to construct a predictive scoring system for 30-day event risk. This score stratified 30-day event risk linearly and demonstrated good predictive accuracy (area under the curve: 0.786; 95% CI 0.712-0.860).

CONCLUSIONS: Four clinical and three hemodynamic factors were significantly associated with 30-day events following PVAD weaning, leading to the development of the UNLOADERS-PVAD Weaning Score. This scoring system facilitates accurate risk stratification before PVAD weaning, guiding clinical decisions regarding further interventions.

TRIAL REGISTRATION: UMIN000052966.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Ikeda Y, Saku K, Nakata J, et al. UNLOADERS-PVAD Weaning Score: predicting post-weaning adverse events in cardiogenic shock patients supported by microaxial flow pump. J Intensive Care. 2025. PMID: 41188967. doi:10.1186/s40560-025-00830-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。